<DOC>
	<DOCNO>NCT01584518</DOCNO>
	<brief_summary>The long-range goal proposal decrease morbidity mortality relate pulmonary edema congestive heart failure ( CHF ) post-operative patient . The short-range goal determine mechanistic endpoint therapy impend heart failure initiate terminate base B-type natriuretic peptide ( BNP ) level . The investigator propose utilize changing level BNP surrogate marker CHF .</brief_summary>
	<brief_title>B-type Natriuretic Peptide Surrogate Marker Guiding Post-operative Fluid Off-loading</brief_title>
	<detailed_description>Creighton University Medical Center 334-bed Level I Trauma Center host wide variety surgical trauma patient . Many patient , include especially pre-existing cardiac morbidity , develop symptom congestive heart failure ( CHF ) follow trauma surgical intervention combination physiological factor include third spacing follow self-diuresis , decrease contractility post injury . Normally , follow onset CHF , surgeon begin treatment base clinical judgment hemodynamic parameter radiographic finding . CHF known increase morbidity , mortality , hospital length stay overall expenditure health care system preventative measure direct treatment modality potential improve patient care healthcare economics . BNP , also know beta-natriuretic protein CHF peptide , cardiac neuro-hormone synthesize cardiac myocytes . It release preproBNP peptide 134 amino acid cleave proBNP ( 108 amino acid ) signal peptide 26 amino acid . ProBNP subsequently cleave BNP ( 32 amino acid ) inactive N-terminal proBNP peptide ( NBNP ; 76 amino acid ) . The effect BNP vasodilation , natriuresis diuresis1 . Left ventricular end-diastolic wall stress ( EDWS ) measurement ejection fraction well establish surrogate predict onset CHF require invasive procedure cardiac catheterization . The mainstay treatment CHF diuretic drug try remove excess fluid patient . In project plan identify patient risk CHF divide two group . In one group BNP use guide diuretic dosage conventional clinical parameter use .</detailed_description>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>General Surgery patient history coronary artery disease , congestive heart failure , pulmonary hypertension Cardiac surgery patient undergo CABG ( coronary artery bypass graft ) valve replacement 1 . Recent myocardial infarction ( within 3 month ) . 2 . ASA class 4 . 3 . Emergency surgery .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>